ICD 10 CM E11.3492 | Description & Clinical Information

ICD 10 E11.3492 describes a medical condition characterized by inadequate production or utilization of insulin, resulting in elevated levels of blood glucose, and severe nonproliferative diabetic retinopathy of the left eye, which includes dot hemorrhages, microaneurysms, and intraretinal microvascular abnormalities, but does not involve swelling of the macula, the area of the retina responsible for sharp vision.

Official Description Of E11.3492

The ICD 10 CM book defines ICD 10 code E11.3492 as:

When To Use E11.3492

The diagnosis describes by the ICD 10 CM E11.3492 code is Nonproliferative Diabetic Retinopathy (NPDR). It is a condition that occurs due to damage to the blood vessels in the retina. The disease is common in people who have Type 2 Diabetes Mellitus (DM). NPDR is characterized by lesions that are confined to the retina, including microaneurysms, small dot and blot hemorrhages, splinter hemorrhages, and intraretinal microvascular abnormalities.

The severity of NPDR is categorized as mild, moderate, or severe, based on the number and extent of the lesions present. Severe NPDR is characterized by the occurrence of dot hemorrhages and microaneurysms in all four quadrants, venous beading in two quadrants, and intraretinal microvascular abnormalities in at least one quadrant. Patients with type 2 DM and severe NPDR of the left eye without macular edema may experience a wide range of symptoms, including pain in the eyes, blurred vision, double vision or diplopia, retinal detachment, headache, and dizziness.

People with Type 2 DM may experience general symptoms such as increased urination, thirst, extreme hunger, fatigue, weight loss, slow-healing sores, and frequent infections, among others. Health care providers typically diagnose the disease based on the patient’s medical history, a physical and eye examination, and signs and symptoms. Laboratory tests, including blood tests for fasting plasma glucose, 2-hour plasma glucose, lipid profile, and HbA1c, and a urine test are required to confirm the diagnosis.

To assess retinal vasculature, healthcare providers may perform a fluorescein angiography. The treatment for NPDR depends on the severity of the disease. Laser photocoagulation may be used to treat dot hemorrhages, microaneurysms, and intraretinal microvascular abnormalities. Additional medication, such as steroids, may be administered to reduce inflammation. Sometimes, surgery may be needed to reduce intraocular pressure or correct nerve damage.

Type 2 DM is treated with oral drug therapy to improve glycemic control and prevent subsequent complications. In severe cases, insulin is used, depending on the glucose levels in the patient’s blood. Healthcare providers also recommend lifestyle changes, healthy eating habits, and exercise to manage the disease.

Ultimately, the diagnosis of NPDR and its management require a comprehensive approach that considers the needs and individual circumstances of the patient. Regular medical checkups may be necessary to monitor any changes in the retina and the progression of the disease, as well as to address any new health issues that may arise. With proper care and attention, people with Type 2 DM and NPDR can manage their disease effectively and preserve their vision.